Skip to main content

Table 1 Characteristics of subjects with hypertension and their COVID-19 test results

From: Does Losartan reduce the severity of COVID-19 in hypertensive patients?

Variables

Positive PCR

Negative PCR

P value

Losartan usage

 

0.054**

yes

59

102

no

42

77

Age (Mean±SD)

67.45±13.25

63.07±13.64

0.009*

LOS (Mean±SD)

9.02±6.40

8.14±6.27

0.285*

Admission status

  

0.593**

In-patient

176

99

Out-patient

3

2

ICU admission

  

0.031**

Yes

15

17

No

152

79

Final outcome

  

0.298**

Alive

156

91

Dead

23

10

Chronic liver disease

  

0.639**

Yes

0

1

No

101

178

DM

  

0.473**

Yes

39

77

No

62

102

CVD

  

0.20**

Yes

66

103

No

35

76

CND

  

0.693**

Yes

4

4

No

97

175

Chronic Lung Disease

  

0.027**

Yes

15

12

No

86

167

CKD

  

0.002**

Yes

15

8

No

86

171

Cancer

  

0.681**

Yes

1

1

No

100

178

  1. Abbreviations: PCR: polymerase chain reaction, SD: standard deviation, LOS: length of stay, ICU: intensive care unit, DM: diabetes mellitus, CVD: cardiovascular diseases, CND: chronic neurological diseases, CKD: chronic kidney diseases. *Independent T test was used. **Exact test was used